GlassScriptPhysician profile
Roddy Darrell Green
NPI 1801821780
$1,307.65
in general payments reported to CMS, 2019-2025
20 companies · $87.52 in 2025
The $87.52 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $431 · 2021: $131 · 2022: $28.08 · 2023: $25.82 · 2024: $101 · 2025: $87.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $224.61 | 2019-2020 | |
| Novo Nordisk INC | $182.09 | 2019-2020 | |
| Abbvie INC. | $172.89 | 2020-2024 | |
| Amgen INC. | $115.51 | 2019-2020 | |
| Lilly USA, LLC | $96.13 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Amarin Pharma, INC. | $92.66 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $75.74 | 2019 | |
| Glaxosmithkline, LLC. | $63.29 | 2019-2023 | Arexvy |
| Abbott Laboratories | $47.82 | 2024 | Freestyle Libre 3 |
| Astellas Pharma US INC | $39.33 | 2024-2025 | Veozah |
| Pfizer INC. | $30.97 | 2019-2022 | |
| Genentech USA, INC. | $30.72 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $26.40 | 2019-2020 | |
| Shire North American Group INC | $19.12 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.93 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $18.23 | 2019 | |
| Dexcom, INC. | $16.40 | 2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $13.04 | 2020 | |
| Adlon Therapeutics L.P. | $12.32 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roddy Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.